Fresenius Medical Care names Shervin J. Korangy CEO, succeeding Helen Giza

FMS•2026-10-07

Fresenius Medical Care named Shervin J. Korangy CEO and chairman of the management board, effective Oct. 12, 2026. Helen Giza will leave the company at the end of Oct. 11, 2026.

1. CEO transition

Korangy resigned from Fresenius Medical Care’s supervisory board before taking the top executive role. Giza will leave the company at the end of Oct. 11, 2026.

Fresenius Medical Care names Shervin J. Korangy CEO, succeeding Helen Giza

1. CEO transition

Related News

Serra Ventures-backed Dragos closes Accenture majority-stake sale

Cboe Clear Europe expands SFT clearing service to U.S. equities

Nasdaq trade halt: volatility trading pause at 10:39 a.m.

Nasdaq trade halt continues; reason not available at 10:57 a.m.

Chevron says it is closely monitoring projected path of Tropical Storm Isaias